Taj pharmaceuticals ltd, multiple sclerosis (ms)

MEDGADGET



ECHOJOURNAL

POPULAR

PASSMIX

CATEGORIES



SUBSCRIBE

SUBMIT

ABOUT

+ FOLLOW

✏ SUBMIT PR





* LOG IN









Multiple sclerosis (MS) Therapeutic Pipeline Market Review, H2 2017 

MARCH 7TH, 2017

 Facebook

WISEGUY REPORTS

  Twitter



RELEASES

  Google+

  LinkedIn

RECENT POSTS BodyCap e-Celsius Electronic Pill for Core Body Temperature Monitoring

W ith PDFmyURL anyone can convert entire websites to PDF!

Minimally Invasive Surgery Congress 2017: A Quick Summary

Bellion Spirits Vodka: A Liver Friendly Spirit?

Jet Powered Pill Shoots Vaccine Into Cheek to Avoid Injections

Sum m ary

ZOLL's Hospital Wearable Defibrillator FDA Approved

Multiple sclerosis (MS) is a potentially debilitating disease in which body’s immune system eats away at the protective sheath (myelin) that covers nerves.

Damage to myelin causes interference in the communication between brain,

INTERV IEWS & REV IEWS

spinal cord and other areas of body. Symptoms include numbness or weakness in one or more limbs, double vision or blurring of vision, tingling or pain in parts of body, fatigue and slurred speech. The predisposing factors include age, gender, family history and certain infections.

GET SAMPLE REPORT @ https://w w w .w iseguy reports.com /sam plerequest/839587 -m ultiple-sclerosis-pipeline-review -h2-2016

W ith PDFmyURL anyone can convert entire websites to PDF!

Minimally Invasive Surgery Congress 2017: A Quick Summary

Koogeek S1 Smart Health Scale Review

Report High ligh ts Pharmaceutical and H ealthcare latest pipeline guide Multiple Sclerosis –

Medgadget's Coverage of the Inaugural AdvaMed Digital MedTech Conference

Pipeline Review, H 2 2016, provides comprehensive information on the therapeutics under development for Multiple Sclerosis (Central N ervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the therapeutics,

Anders Wold, GE Healthcare’s CEO of Clinical Care Solutions on What To Think About When Running a Medtech Business

its complete research and development history and latest news and press releases.

The Multiple Sclerosis (Central N ervous System) pipeline guide also reviews of key players involved in therapeutic development for Multiple Sclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 5, 9, 30, 32, 173, 36 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 4, 46 and 2 molecules, respectively.

Multiple Sclerosis (Central N ervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

W ith PDFmyURL anyone can convert entire websites to PDF!

CleanSlate UV Sanitizer for Mobile Devices in Healthcare: An Interview

Scope – The pipeline guide provides a snapshot of the global therapeutic landscape of Multiple Sclerosis (Central N ervous System).

– The pipeline guide reviews pipeline therapeutics for Multiple Sclerosis (Central N ervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Multiple Sclerosis (Central N ervous System) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Multiple Sclerosis (Central N ervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Multiple Sclerosis (Central N ervous System)

W ith PDFmyURL anyone can convert entire websites to PDF!

Reason s to buy – Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

– Find and recognize significant and varied types of therapeutics under development for Multiple Sclerosis (Central N ervous System).

– Classify potential new clients or partners in the target demographic.

– Develop tactical initiatives by understanding the focus areas of leading companies.

– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

– Formulate corrective measures for pipeline projects by understanding Multiple Sclerosis (Central N ervous System) pipeline depth and focus of Indication therapeutics.

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Con ten t: Key Poin ts Table of Contents 2 W ith PDFmyURL anyone can convert entire websites to PDF!

Introduction 10 Multiple Sclerosis Overview 11 Therapeutics Development 12 Multiple Sclerosis – Therapeutics under Development by Companies 14 Multiple Sclerosis – Therapeutics under Investigation by Universities/Institutes 31 Multiple Sclerosis – Pipeline Products Glance 34 Multiple Sclerosis – Products under Development by Companies 38 Multiple Sclerosis – Products under Investigation by Universities/Institutes 58 Multiple Sclerosis – Companies Involved in Therapeutics Development 62 Multiple Sclerosis – Therapeutics Assessment 250 Drug Profiles 291 Multiple Sclerosis – Dormant Projects 839 Multiple Sclerosis – Discontinued Products 864 Multiple Sclerosis – Product Development Milestones 869 …Con tin ued

ACCESS REPORT @ https://w w w .w iseguy reports.com /reports/839587 m ultiple-sclerosis-pipeline-review -h2-2016 W ith PDFmyURL anyone can convert entire websites to PDF!

Con tact In fo: N ORAH TREN T Partn er Relation s & Mark etin g Man ager sales@ w iseguy reports.com Ph : +1-646-845-9349 (U S) Ph : +44 208 133 9349 (U K)

Get in touch : Lin k edIn : w w w .lin k edin .com /com pan y /4828928 Tw itter: h ttps://tw itter.com /W iseGuy Reports

Facebook : h ttps://w w w .facebook .com /W iseguy reports-1009007 869213183/? fref=ts

Sign up and submit a press release W ith PDFmyURL anyone can convert entire websites to PDF!

RELATED POSTS RELEASES

RELEASES

RELEASES

MARCH 14TH, 2017

MARCH 14TH, 2017

MARCH 14TH, 2017

Global Leuprorelin Acetate Market 2016 Regional Outlook, Analysis, Size, Share, Forecast -2021

Remicade Biosimilar Market Forecast and Segments, 2016-2026

Malaysia Bone Replacement Market Latest Report Includes Market Sales Present Situation and Outlook

by Applications/End Industrials 2022

RELEASES

RELEASES

MARCH 14TH, 2017

MARCH 14TH, 2017

Allergic RhinoConjunctivitis-Pipeline Market Reviews, Business Outlook and Procurement Report

Global Knee Prosthesis Market 2016 Regional Outlook, Analysis, Size, Share, Forecast -2021

W ith PDFmyURL anyone can convert entire websites to PDF!

RELEASES

MARCH 14TH, 2017

Global Knee Ankle Foot Orthoses Market 2016 Regional Outlook, Analysis, Size, Share, Forecast -2021



SUBSCRIBE

CONTACT US

SUBMIT

ABOUT BACK TO TOP

At Medgadget we report on the latest medical technology news, interview leaders in the field, and file dispatches from medical events from around the world.

     © Medgadget, LLC. 2004-2016. All rights reserved. | The Medical Revolution Will Be Blogged.

W ith PDFmyURL anyone can convert entire websites to PDF!

 About

 Contact

 Terms of Service

 Privacy

 Submit press release Advertise

